Patent · US Active

Crystalline form of compound and uses thereof in medicine

US11993664B2 · kind B2 · utility

1Cited by

1References

9Claims

0Family size

Assignee

WATERSTONE PHARMACEUTICALS(WUHAN) CO., LTD. · CN

Inventors

Jian Cui · Edison, US
Yao Yu · Kunming, CN
Minglong HU · Daguantang, CN

Key dates

Filing date	Aug 22, 2019
Grant date	May 28, 2024
Priority date	—
Expiry date	May 30, 2041

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A crystalline form A of the compound having formula (I) and uses thereof in medicine are described. Specifically, it relates to crystalline form A and pharmaceutically compositions thereof. Furthermore, it relates to the uses of crystalline form A disclosed herein and pharmaceutically compositions thereof disclosed herein in the manufacture of a medicament, especially in the manufacture of a medicament for preventing, managing, treating or lessening hepatitis C vims (HCV) infection.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.